60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$1.39 +0.14 (+11.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

60 Degrees Pharmaceuticals (SXTP) Return on Sales [ROS] (2022 - 2026)

Updated

60 Degrees Pharmaceuticals (SXTP) recorded Return on Sales [ROS] of -1092.41% in Q2 2026, up 499.08 percentage points from -1591.50% a year earlier and up 200.04 percentage points from the prior quarter.

Analysis

60 Degrees Pharmaceuticals (SXTP) Return on Sales [ROS] (2022 - 2026) Analysis & Trends

On a TTM basis, 60 Degrees Pharmaceuticals' Return on Sales [ROS] came in at -774.90% as of Jun 30, 2026, up 425.77 percentage points year-over-year; for FY2025, it was -771.64%, up 827.38 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a three-year change of +12.59 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -1599.01% in FY2024 (+433.77 pp), -2032.78% in FY2023 (-1248.56 pp) and -784.22% in FY2022.
  • Quarterly Return on Sales [ROS] has ranged from -5536.13% in Q1 2023 to -127.90% in Q3 2022 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in seven of the last eight quarters, with an average year-over-year change of +694.23 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 4265.76 percentage points in Q1 2024, against a drop of 2844.98 percentage points in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1292.45% (Q1 2026), -631.99% (Q4 2025) and -531.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 60 Degrees Pharmaceuticals 3.70 Mn 2.59 Mn 56,798.00 -1,092.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,092.41%
Mar 31, 2026 -1,292.45%
Dec 31, 2025 -631.99%
Sep 30, 2025 -531.42%
Jun 30, 2025 -1,591.50%
Mar 31, 2025 -1,168.40%
Dec 31, 2024 -854.72%
Sep 30, 2024 -1,566.00%
Jun 30, 2024 -3,351.75%
Mar 31, 2024 -1,270.37%
Dec 31, 2023 -1,507.12%
Sep 30, 2023 -2,972.89%
Jun 30, 2023 -1,323.65%
Mar 31, 2023 -5,536.13%
Sep 30, 2022 -127.90%
Jun 30, 2022 -1,520.64%
API Access

60 Degrees Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SXTP&period=max&api_key=YOUR_API_KEY